Kura Oncology Inc. (KURA)

6.38

-0.22 (-3.33%)

At close: Apr 01, 2025, 3:59 PM

6.38

-0.09%

After-hours: Apr 01, 2025, 07:17 PM EDT

Kura Oncology Cash Flow Statement

Chart Mode

Year	FY24	FY23	FY22	FY21	FY20
Net Income	-173.98M	-152.63M	-135.84M	-130.47M	-89.63M
Depreciation & Amortization	848K	849K	759K	558K	194K
Stock-Based Compensation	33.9M	28.08M	26.32M	23.58M	12.81M
Other Working Capital	270.97M	7.82M	-2.18M	-706K	707K
Other Non-Cash Items	-12.62M	-8.94M	1.68M	399K	410K
Deferred Income Tax	n/a	n/a	n/a	4.6M	n/a
Change in Working Capital	286.17M	7.82M	-2.98M	-3.22M	6.38M
Operating Cash Flow	134.32M	-124.82M	-110.06M	-104.55M	-69.83M
Capital Expenditures	-472K	-168K	-626K	-1.15M	-2.17M
Acquisitions	n/a	n/a	-33.25K	125.69K	97.77K
Purchase of Investments	-659.05M	-409.82M	-270.65M	-445.66M	-320.96M
Sales Maturities Of Investments	557.93M	425.55M	303.91M	319.97M	223.2M
Other Investing Acitivies	n/a	n/a	33.25K	-125.69K	-97.77K
Investing Cash Flow	-101.59M	15.56M	32.63M	-126.83M	-99.94M
Debt Repayment	n/a	n/a	10M	-7.25M	-250K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	8.6M	1.21M	3.84M	-611K	10.25M
Financial Cash Flow	154.42M	94.78M	38.56M	-3.44M	469.33M
Net Cash Flow	187.14M	-14.48M	-38.87M	-234.82M	299.57M
Free Cash Flow	133.84M	-124.99M	-110.69M	-105.7M	-72M